Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes. / Torekov, Signe Sørensen; Kipnes, M S; Harley, R E; Holst, J J; Ehlers, M R.
I: Diabetes, Obesity and Metabolism, Bind 13, Nr. 7, 2011, s. 639-43.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes
AU - Torekov, Signe Sørensen
AU - Kipnes, M S
AU - Harley, R E
AU - Holst, J J
AU - Ehlers, M R
N1 - © 2011 Blackwell Publishing Ltd.
PY - 2011
Y1 - 2011
N2 - To evaluate the dose-response relationship of the recombinant glucagon-like peptide-1 (7-36) amide (rGLP-1) administered by continuous subcutaneous infusion (CSCI) in subjects with type 2 diabetes, with respect to reductions in fasting, postprandial and 11-h serum glucose profiles.
AB - To evaluate the dose-response relationship of the recombinant glucagon-like peptide-1 (7-36) amide (rGLP-1) administered by continuous subcutaneous infusion (CSCI) in subjects with type 2 diabetes, with respect to reductions in fasting, postprandial and 11-h serum glucose profiles.
KW - Blood Glucose
KW - C-Peptide
KW - Diabetes Mellitus, Type 2
KW - Dose-Response Relationship, Drug
KW - Double-Blind Method
KW - Female
KW - Glucagon-Like Peptide 1
KW - Humans
KW - Hypoglycemic Agents
KW - Infusions, Subcutaneous
KW - Male
KW - Middle Aged
KW - Peptide Fragments
KW - Placebos
KW - Postprandial Period
U2 - 10.1111/j.1463-1326.2011.01388.x
DO - 10.1111/j.1463-1326.2011.01388.x
M3 - Journal article
C2 - 21362122
VL - 13
SP - 639
EP - 643
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
SN - 1462-8902
IS - 7
ER -
ID: 40246465